▶ 調査レポート

ヒトロタウイルスワクチンの世界市場2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Human Rotavirus Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。ヒトロタウイルスワクチンの世界市場2020年:メーカー別、地域別、種類・用途別 / Global Human Rotavirus Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D0GIR-06538資料のイメージです。• レポートコード:D0GIR-06538
• 出版社/出版日:GlobalInfoResearch / 2020年9月18日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ヒトロタウイルスワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒトロタウイルスワクチンの種類別市場規模(Rotarix、RotaTeq、Rotavac、ロタビン-M1、蘭州ラム、その他)、用途別市場規模(病院・クリニック、学術・研究、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Bharat Biotech、Merck、GlaxoSmithKline
・地域別グローバル市場分析 2015年-2020年
・ヒトロタウイルスワクチンの北米市場(アメリカ、カナダ、メキシコ)
・ヒトロタウイルスワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ヒトロタウイルスワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ヒトロタウイルスワクチンの南米市場(ブラジル、アルゼンチン)
・ヒトロタウイルスワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:Rotarix、RotaTeq、Rotavac、ロタビン-M1、蘭州ラム、その他
・用途別分析:病院・クリニック、学術・研究、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Human Rotavirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.0% in the forecast period of 2020 to 2025 and will expected to reach USD 8763 million by 2025, from USD 6949.3 million in 2019.

The Human Rotavirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Human Rotavirus Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Human Rotavirus Vaccine market has been segmented into
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others

By Application, Human Rotavirus Vaccine has been segmented into:
Hospitals & Clinics
Academic And Research
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Rotavirus Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Rotavirus Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Rotavirus Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Human Rotavirus Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Human Rotavirus Vaccine Market Share Analysis
Human Rotavirus Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Rotavirus Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Rotavirus Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Human Rotavirus Vaccine are:
Bharat Biotech
Merck
GlaxoSmithKline

Among other players domestic and global, Human Rotavirus Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rotavirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Rotavirus Vaccine, with price, sales, revenue and global market share of Human Rotavirus Vaccine in 2018 and 2019.
Chapter 3, the Human Rotavirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rotavirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Human Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Human Rotavirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Human Rotavirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Rotavirus Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Rotavirus Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals & Clinics
1.3.3 Academic And Research
1.3.4 Others
1.4 Overview of Global Human Rotavirus Vaccine Market
1.4.1 Global Human Rotavirus Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bharat Biotech SWOT Analysis
2.1.4 Bharat Biotech Product and Services
2.1.5 Bharat Biotech Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlaxoSmithKline SWOT Analysis
2.3.4 GlaxoSmithKline Product and Services
2.3.5 GlaxoSmithKline Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Human Rotavirus Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Human Rotavirus Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Rotavirus Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Human Rotavirus Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Human Rotavirus Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Human Rotavirus Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Rotavirus Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Human Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Human Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Human Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Human Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.4 France Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Human Rotavirus Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Human Rotavirus Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Human Rotavirus Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.5 India Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Human Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Human Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Human Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Human Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Human Rotavirus Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Human Rotavirus Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Human Rotavirus Vaccine Price by Type (2015-2020)
11 Global Human Rotavirus Vaccine Market Segment by Application
11.1 Global Human Rotavirus Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Human Rotavirus Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Human Rotavirus Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Human Rotavirus Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Human Rotavirus Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Human Rotavirus Vaccine Market Forecast (2021-2025)
12.2.2 Europe Human Rotavirus Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Human Rotavirus Vaccine Market Forecast (2021-2025)
12.2.4 South America Human Rotavirus Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Human Rotavirus Vaccine Market Forecast (2021-2025)
12.3 Human Rotavirus Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Human Rotavirus Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Human Rotavirus Vaccine Market Share Forecast by Type (2021-2025)
12.4 Human Rotavirus Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Human Rotavirus Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Human Rotavirus Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Human Rotavirus Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Rotavirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Rotavirus Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 8. Bharat Biotech Human Rotavirus Vaccine Major Business
Table 9. Bharat Biotech Human Rotavirus Vaccine Total Revenue (USD Million) (2018-2019)
Table 10. Bharat Biotech SWOT Analysis
Table 11. Bharat Biotech Human Rotavirus Vaccine Product and Services
Table 12. Bharat Biotech Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Human Rotavirus Vaccine Major Business
Table 15. Merck Human Rotavirus Vaccine Total Revenue (USD Million) (2018-2019)
Table 16. Merck SWOT Analysis
Table 17. Merck Human Rotavirus Vaccine Product and Services
Table 18. Merck Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Human Rotavirus Vaccine Major Business
Table 21. GlaxoSmithKline Human Rotavirus Vaccine Total Revenue (USD Million) (2018-2019)
Table 22. GlaxoSmithKline SWOT Analysis
Table 23. GlaxoSmithKline Human Rotavirus Vaccine Product and Services
Table 24. GlaxoSmithKline Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Global Human Rotavirus Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 26. Global Human Rotavirus Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 27. Global Human Rotavirus Vaccine Sales by Regions (2015-2020) (K Units)
Table 28. Global Human Rotavirus Vaccine Sales Market Share by Regions (2015-2020)
Table 29. Global Human Rotavirus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 30. North America Human Rotavirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 31. North America Human Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Table 32. North America Human Rotavirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 33. North America Human Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 34. Europe Human Rotavirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 35. Europe Human Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Table 36. Europe Human Rotavirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 37. Asia-Pacific Human Rotavirus Vaccine Sales by Regions (2015-2020) (K Units)
Table 38. Asia-Pacific Human Rotavirus Vaccine Sales Market Share by Regions (2015-2020)
Table 39. Asia-Pacific Human Rotavirus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 40. South America Human Rotavirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 41. South America Human Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Table 42. South America Human Rotavirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 43. South America Human Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Human Rotavirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 45. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Table 46. Middle East & Africa Human Rotavirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 47. Middle East & Africa Human Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 48. Global Human Rotavirus Vaccine Sales by Type (2015-2020) (K Units)
Table 49. Global Human Rotavirus Vaccine Sales Share by Type (2015-2020)
Table 50. Global Human Rotavirus Vaccine Revenue by Type (2015-2020) (USD Million)
Table 51. Global Human Rotavirus Vaccine Revenue Share by Type (2015-2020)
Table 52. Global Human Rotavirus Vaccine Sales by Application (2015-2020) (K Units)
Table 53. Global Human Rotavirus Vaccine Sales Share by Application (2015-2020)
Table 54. Global Human Rotavirus Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 55. Global Human Rotavirus Vaccine Market Share Forecast by Regions (2021-2025)
Table 56. Global Human Rotavirus Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 57. Global Human Rotavirus Vaccine Market Share Forecast by Type (2021-2025)
Table 58. Global Human Rotavirus Vaccine Sales Forecast by Application (2021-2025)
Table 59. Global Human Rotavirus Vaccine Market Share Forecast by Application (2021-2025)
Table 60. Direct Channel Pros & Cons
Table 61. Indirect Channel Pros & Cons
Table 62. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Human Rotavirus Vaccine Picture
Figure 2. Global Sales Market Share of Human Rotavirus Vaccine by Type in 2019
Figure 3. Rotarix Picture
Figure 4. RotaTeq Picture
Figure 5. Rotavac Picture
Figure 6. Rotavin-M1 Picture
Figure 7. Lanzhou lamb Picture
Figure 8. Others Picture
Figure 9. Human Rotavirus Vaccine Sales Market Share by Application in 2018
Figure 10. Hospitals & Clinics Picture
Figure 11. Academic And Research Picture
Figure 12. Others Picture
Figure 13. Global Human Rotavirus Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Human Rotavirus Vaccine Sales Market Share by Manufacturer in 2019
Figure 34. Global Human Rotavirus Vaccine Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Human Rotavirus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Human Rotavirus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Human Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Human Rotavirus Vaccine Revenue Market Share by Regions (2015-2020)
Figure 41. Global Human Rotavirus Vaccine Revenue Market Share by Regions in 2018
Figure 42. North America Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 43. Europe Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 45. South America Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Human Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 47. North America Human Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Human Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Figure 49. North America Human Rotavirus Vaccine Sales Market Share by Countries in 2018
Figure 50. North America Human Rotavirus Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Human Rotavirus Vaccine Revenue Market Share by Countries in 2018
Figure 52. United States Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Human Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Human Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Human Rotavirus Vaccine Revenue Market Share by Countries in 2019
Figure 58. Germany Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Human Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Human Rotavirus Vaccine Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Human Rotavirus Vaccine Revenue Market Share by Regions 2019
Figure 66. China Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Human Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Human Rotavirus Vaccine Sales Market Share by Countries in 2019
Figure 73. South America Human Rotavirus Vaccine Revenue Market Share by Countries in 2019
Figure 74. Brazil Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Human Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Human Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Human Rotavirus Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Human Rotavirus Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Human Rotavirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Human Rotavirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Human Rotavirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Human Rotavirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 90. Middle East & Africa Sales Human Rotavirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel